Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001193125-25-245106

Chief Financial Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Adawi Kamal Chief Financial Officer 2025-10-20 Grant or award +75,000 75,000 D
Derivatives
Adawi Kamal Chief Financial Officer 2025-10-20 Grant or award · Stock Option (Right to Buy) +375,000 375,000 D
Loading xslF345X05/ownership.xml…